Menu
US
immune-therapies1920
Whitepaper

Leveraging the microbiome to strengthen immune therapeutic response

Researchers are striving to determine where and when relevant bacteria play a role in cancer progression and whether those interactions are localized to the gastrointestinal tract or occur in other tissues before malignancy. Understanding the role bacteria play, whether it be oncogenesis, tumor promotion, or treatment effectiveness, may provide an opportunity for intervention at the microbiome level in favor of cancer regression.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Leveraging the microbiome to strengthen immune therapeutic response

Download Whitepaper